Abstract
Transfusion of red cell concentrates (RMCs) is the administration of red blood cells from a donor to a recipient to correct anemia. Despite improvements in blood preservation and treatment techniques in developed countries, the risk of transfusion-related adverse reactions remains significant. In Sub-Saharan Africa (SSA), while haemovigilance is not well organized and the majority of health institutions do not always screen for irregular agglutinins before each blood transfusion. Therefore, the restrictive transfusion policy defined by a transfusion threshold of blood haemoglobin concentration between 7 and 8 g/dl should be in place. Received: March 10th, 2021 Accepted: July 21st, 2021
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
